Zoetis Inc. (ZTS) income statement
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · 14,500 employees · CEO Kristin C. Peck
- Price
- $82.11 -7.95%
- Market cap
- $33.9B
- Enterprise value
- $32.8B
- Last report
- Q3 '26 filed 2026-11-05
- Next report
- 2027-02-11 EPS est. $1.29
Zoetis Inc. (ZTS) reported revenue of $2.39B for Q3 '26 (-0.4% year on year), operating income of $937M (39.2% of revenue) and net income of $591M. Over the last four quarters revenue was $9.51B.
Income statement
| Income statement | Trend | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.21B | $2.19B | $2.36B | $2.39B | $2.32B | $2.22B | $2.46B | $2.4B | $2.39B | $2.26B | $2.47B | $2.39B | |
| Cost of revenue | $765M | $680M | $703M | $736M | $741M | $654M | $682M | $715M | $743M | $641M | $673M | $698M | |
| Gross profit | $1.45B | $1.51B | $1.66B | $1.65B | $1.58B | $1.57B | $1.78B | $1.69B | $1.64B | $1.62B | $1.8B | $1.69B | |
| Research & development | $174M | $162M | $171M | $167M | $186M | $157M | $172M | $170M | $199M | $180M | $173M | $174M | |
| Other operating expenses | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $31M | $93M | $0 | |
| Operating expenses | $739M | $709M | $752M | $732M | $811M | $720M | $789M | $749M | $818M | $799M | $858M | $756M | |
| Operating income | $709M | $801M | $906M | $920M | $765M | $846M | $989M | $936M | $826M | $822M | $937M | $937M | |
| Interest income | $26M | $32M | $24M | $23M | $27M | $23M | $19M | $26M | $25M | $21M | $0 | $0 | |
| Interest expense | $59M | $62M | $63M | $61M | $56M | $59M | $58M | $64M | $57M | $62M | $61M | $62M | |
| Other non-operating income (gains on investments, FX ...) | $0 | -$8M | $63M | -$15M | -$23M | -$23M | $29M | -$9M | $8M | $2M | $10M | $0 | |
| Total non-operating income | -$59M | -$54M | -$126M | -$46M | -$33M | -$36M | -$87M | -$49M | -$65M | -$64M | -$71M | -$208M | |
| Income before tax | $650M | $747M | $780M | $874M | $732M | $810M | $902M | $887M | $761M | $758M | $866M | $729M | |
| Income tax | $127M | $148M | $156M | $182M | $151M | $179M | $184M | $166M | $158M | $157M | $175M | $138M | |
| Net income | $525M | $599M | $624M | $682M | $581M | $631M | $718M | $721M | $603M | $601M | $691M | $591M | |
| EPS (basic) | $1.14 | $1.31 | $1.37 | $1.51 | $1.29 | $1.41 | $1.61 | $1.63 | $1.38 | $1.42 | $1.65 | $1.44 | |
| EPS (diluted) | $1.14 | $1.31 | $1.37 | $1.50 | $1.29 | $1.41 | $1.61 | $1.63 | $1.37 | $1.42 | $1.65 | $1.44 | |
| Shares (basic, weighted) | 459M | 458M | 456M | 453M | 451M | 448M | 445M | 443M | 438M | 422M | 418M | 412M | |
| Shares (diluted, weighted) | 460M | 459M | 456M | 454M | 451M | 448M | 446M | 443M | 439M | 422M | 418M | 412M | |
| Depreciation & amortization | $126M | $126M | $127M | $121M | $123M | $119M | $123M | $124M | $121M | $119M | $119M | $0 | |
| EBITDA | $835M | $935M | $970M | $1.06B | $911M | $988M | $1.08B | $1.07B | $939M | $939M | $1.05B | $937M |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.89B | $5.31B | $5.83B | $6.26B | $6.68B | $7.78B | $8.08B | $8.54B | $9.26B | $9.47B | |
| Cost of revenue | $1.75B | $1.86B | $2.03B | $2.15B | $2.22B | $2.46B | $2.6B | $2.71B | $2.86B | $2.79B | |
| Gross profit | $3.14B | $3.44B | $3.8B | $4.11B | $4.46B | $5.31B | $5.48B | $5.83B | $6.4B | $6.67B | |
| Research & development | $376M | $382M | $432M | $457M | $463M | $508M | $539M | $614M | $686M | $698M | |
| Sales & marketing | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $302M | $0 | |
| General & administrative | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.02B | $0 | |
| Operating expenses | $1.74B | $1.72B | $1.92B | $2.1B | $2.19B | $2.51B | $2.55B | $2.77B | $3B | $3.08B | |
| Operating income | $1.4B | $1.73B | $1.88B | $2.02B | $2.27B | $2.8B | $2.93B | $3.07B | $3.39B | $3.6B | |
| Interest income | $0 | $0 | $31M | $37M | $12M | $6M | $50M | $105M | $106M | $93M | |
| Interest expense | $166M | $175M | $212M | $242M | $249M | $236M | $237M | $258M | $242M | $243M | |
| Other non-operating income (gains on investments, FX ...) | $10M | $27M | -$21M | -$25M | $24M | $79M | $35M | -$125M | $17M | $15M | |
| Total non-operating income | -$176M | -$202M | -$191M | -$217M | -$273M | -$315M | -$272M | -$133M | -$259M | -$237M | |
| Income before tax | $1.23B | $1.53B | $1.69B | $1.8B | $2B | $2.49B | $2.66B | $2.94B | $3.13B | $3.36B | |
| Income tax | $409M | $663M | $266M | $301M | $360M | $454M | $545M | $596M | $637M | $687M | |
| Net income | $821M | $864M | $1.43B | $1.5B | $1.64B | $2.04B | $2.11B | $2.34B | $2.49B | $2.67B | |
| EPS (basic) | $1.66 | $1.76 | $2.96 | $3.14 | $3.44 | $4.29 | $4.51 | $5.08 | $5.47 | $6.03 | |
| EPS (diluted) | $1.65 | $1.75 | $2.93 | $3.11 | $3.42 | $4.27 | $4.49 | $5.07 | $5.47 | $6.02 | |
| Shares (basic, weighted) | 496M | 490M | 483M | 478M | 476M | 474M | 469M | 461M | 454M | 443M | |
| Shares (diluted, weighted) | 498M | 493M | 487M | 482M | 479M | 477M | 470M | 462M | 455M | 444M | |
| Depreciation & amortization | $240M | $242M | $308M | $412M | $441M | $448M | $465M | $491M | $497M | $487M | |
| EBITDA | $1.63B | $1.94B | $2.21B | $2.46B | $2.69B | $3.17B | $3.36B | $3.69B | $3.87B | $4.07B |
Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-06